Kura Oncology, Inc.
NASDAQ:KURA
20.26 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.849 | 0.759 | 0.558 | 0.194 | 0 | 0.01 | 0.03 | 0.031 | 0.02 | 0.024 | 0.023 | 0.022 | 0.023 | 0.021 | 0.019 | 0 |
| Gross Profit
| -0.849 | -0.759 | -0.558 | -0.194 | 0 | -0.01 | -0.03 | -0.031 | -0.02 | -0.024 | -0.023 | -0.022 | -0.023 | -0.021 | -0.019 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 115.235 | 92.812 | 84.721 | 60.397 | 47.826 | 46.787 | 26.426 | 20.404 | 17.777 | 8.046 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 50.569 | 47.053 | 46.537 | 31.502 | 19.653 | 16.096 | 9.651 | 7.963 | 6.088 | 3.846 | 0.022 | 0.023 | 0.021 | 0.021 | 0.019 | 0 |
| Selling & Marketing Expenses
| -0.849 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 49.72 | 47.053 | 46.537 | 31.502 | 19.653 | 16.096 | 9.651 | 7.963 | 6.088 | 3.846 | 0.022 | 0.023 | 0.021 | 0.021 | 0.019 | 0 |
| Other Expenses
| 0 | 4.025 | 0.792 | 2.274 | 4.339 | 2.436 | 0.643 | 0.807 | 1.24 | 1.996 | 0 | 0 | 0 | 0 | 0 | -0.034 |
| Operating Expenses
| 164.955 | 139.865 | 131.258 | 91.899 | 67.479 | 62.883 | 36.077 | 28.367 | 23.865 | 10.902 | 0.022 | 0.023 | 0.021 | 0.021 | 0.019 | -0.034 |
| Operating Income
| -165.804 | -140.624 | -131.816 | -92.093 | -67.479 | -62.883 | -36.077 | -28.367 | -23.865 | -11.802 | -0.022 | -0.023 | -0.021 | -0.041 | -0.038 | -0.034 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 13.173 | 4.784 | 1.35 | 2.468 | 4.339 | 2.436 | 0.643 | 0.807 | 1.24 | 0.789 | -0.005 | -0.004 | -0.002 | 0.019 | 0.018 | 0 |
| Income Before Tax
| -152.631 | -135.84 | -130.466 | -89.625 | -63.14 | -60.447 | -35.434 | -27.56 | -22.625 | -11.013 | -0.027 | -0.027 | -0.022 | -0.022 | -0.02 | -0.034 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0.229 | -0.558 | -0.194 | -0 | 3.406 | -0.03 | -0.031 | -0.02 | 0.269 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income
| -152.631 | -136.069 | -129.908 | -89.431 | -63.14 | -60.447 | -35.434 | -27.56 | -22.625 | -11.013 | -0.027 | -0.027 | -0.022 | -0.022 | -0.02 | -0.034 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -2.08 | -2.03 | -1.96 | -1.68 | -1.51 | -1.72 | -1.52 | -1.47 | -2.28 | -78.11 | -0.006 | -0.005 | -0.005 | -0.005 | -0.004 | 0 |
| EPS Diluted
| -2.08 | -2.03 | -1.96 | -1.68 | -1.51 | -1.72 | -1.52 | -1.47 | -2.28 | -78.11 | -0.006 | -0.005 | -0.005 | -0.005 | -0.004 | 0 |
| EBITDA
| -164.955 | -139.865 | -131.258 | -91.899 | -67.479 | -62.883 | -36.077 | -28.367 | -23.865 | -11.799 | -0.022 | -0.023 | -0.021 | -0.041 | -0.038 | -0.034 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |